RegulatoryConnect

AI Summary

In November 2025, the Medicines and Healthcare products Regulatory Agency (MHRA) announced the closure of its RegulatoryConnect management system programme. Following a comprehensive review, the agency concluded that the project no longer provides sufficient value for UK taxpayers and that the costs to complete it are too high relative to its expected utility. This decision aligns with the agency's upcoming strategic shift. Despite the programme's wind-down, the MHRA confirms that business operations remain uninterrupted and performance is stable. The existing portal functionality remains active, allowing industry stakeholders to track application progress and view live authorization details, such as license status and linked documentation, using current credentials. Looking ahead, the MHRA is developing a new multi-year strategy for launch in early 2026, which will define its mission through 2030. This future framework will prioritize risk-proportionate regulation, data-driven intelligence, and the integration of Artificial Intelligence (AI) to support the UK life sciences sector. While no immediate corrective actions are required from regulated entities, users are encouraged to utilize existing online guides and webinars for navigating the current portal. Further updates regarding the agency's technological direction and the new 2030 strategy are expected in the coming weeks.